- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Weight Management
The Endocrinology Network® Weight Management clinical resource center is the home of all content related to weight loss and obesity management. Now a full-blown epidemic, the obesity crisis is one of the most prominent and dangerous health crises in the US. This page will provide insight and perspective related to FDA approvals, the latest studies, and guideline updates related to nutrition, obesity, and weight management.
Who is Responsible for Prescribing Weight Loss Medications to Obese Patients with Thomas Wadden, PhD
March 05, 2021
After providing insight into the results of the STEP 1 and STEP 3 trials, Dr. Wadden discusses who he believes the responsibility for prescribing these medications will fall unto if semaglutide receives approval as a weight loss agent.
STEP 1 and STEP 3 Results with Thomas Wadden, PhD
March 02, 2021
Published in late February, results of the STEP 1 and STEP 3 trial give clinicians insight into the effects of 2.4 mg subcutaneous semaglutide as an intervention for weight loss in overweight or obese patients ahead of a potential approval in June 2021.
Diabetes, 3 Other Metabolic Conditions Responsible for 2-in-3 COVID-19 Hospitalizations
March 01, 2021
An AHA study suggests nearly 66% of all COVID-19 hospitalizations could be attributed to the presence of obesity, diabetes, hypertension, or heart failure.
Excess Body Fat Impacts Puberty Timing In Young Women
February 26, 2021
A study of 80 young women is providing clinicians with insight into how total body fat can impact the timing of puberty and levels of pubertal hormones in women.
Digital Self-Monitoring Linked to Improvements in Weight Loss Trials
February 24, 2021
A review of 39 randomized clinical trials examining weight loss interventions is providing clinicians with an overview of engagement rates, mediums used, and effects of digital self-monitoring for weight loss among obese or overweight patients.
Cardiovascular Health During Pregnancy Helps Predict Heart Health in Children, Study Finds
February 18, 2021
An analysis of more than 2k mother-child pairs indicates assessments of maternal cardiovascular health could shed light on the potential for poor cardiovascular health among their children at ages 10-14 years.
Case Report: Shortness of Breath After Cefalexin
February 18, 2021
Our latest case report from Brady Pregerson, MD, features a 62 y/o male with a history of obesity, CAD, anxiety, and COPD presenting with SOB after stating cefalexin. Can you determine the correct diagnosis?
Dietary Interventions and the Role of Nutrition in Obesity with Ariana Chao, PhD, CRNP
February 17, 2021
This episode of the Endocrine Outlook podcast features an interview on dietary interventions and the role of nutrition in obesity management with Ariana Chao, PhD, CRNP, of the University of Pennsylvania.
Chinese Adults More Susceptible to Obesity-Related Health Complications than Other Ethnic Groups
February 11, 2021
An analysis of data from an ethnically diverse cohort of more than 120k patients indicates Chinese adults were more susceptible to obesity-related health complications, such as hypertension, than other racial/ethnic groups.
Obesity Responsible for Up to Half of New Diabetes Cases in the US
February 10, 2021
A new report published in the Journal of the American Heart Association suggests obesity was linked to 30-53% of all new cases of diabetes within the United States.